{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:05:05Z","timestamp":1791032705394,"version":"4.1.0"},"reference-count":29,"publisher":"Bioscientifica","issue":"1","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Steroid hormone receptor antagonists are widely used in clinical medicine, but their use is often complicated by the lack of receptor specificity to presently available drugs. We previously demonstrated an important role of a widely conserved helix 3 (H3)\u2013helix 5 (H5) interaction in determining the sensitivity and specificity of steroid hormone receptors to receptor agonists. Intriguingly, the same H3 residues also play a crucial role in receptor antagonism; mutation of these residues alters the response of these receptors to antagonists. Given the close interaction of H3 and H5 residues at this site, we asked whether H5 residues might also play a role in the sensitivity of these receptors to antagonists. We demonstrate here that modification of H5 residues produces marked changes in the sensitivities of the glucocorticoid and progesterone receptor (PR) to RU486 antagonism. Moreover, while we confirm previous reports that alteration of the H3 residue, Gly 722 prevents RU486-mediated inhibition of the PR, we show that the corresponding substitution in the glucocorticoid receptor does not inhibit RU486-mediated receptor antagonism. Taken together, our data support the notion that RU486 binds differently to these two receptors, providing a potential target for the design of more specific antiglucocorticoid and antiprogestin drugs.<\/jats:p>","DOI":"10.1677\/jme.1.02089","type":"journal-article","created":{"date-parts":[[2006,8,10]],"date-time":"2006-08-10T05:42:47Z","timestamp":1155188567000},"page":"163-173","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-6","source":"Crossref","is-referenced-by-count":16,"title":["Differential interaction of RU486 with the progesterone and glucocorticoid receptors"],"prefix":"10.1530","volume":"37","author":[{"given":"Junhui","family":"Zhang","sequence":"first","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, PO Box 208029, New Haven, Connecticut 06520\u20138029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis T F","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030\u20133498, USA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Geller","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, PO Box 208029, New Haven, Connecticut 06520\u20138029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2006,6,9]]},"reference":[{"key":"2026070808124296300_ARNALDI-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Arnaldi\n              G\n            \n          , Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB et al.2003 Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism885593\u20135602.","DOI":"10.1210\/jc.2003-030871"},{"key":"2026070808124296300_AUZOU-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Auzou\n              G\n            \n          , Fagart J, Souque A, Hellal-Levy C, Wurtz JM, Moras D & Rafestin-Oblin ME 2000 A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones. Molecular Pharmacology58684\u2013691.","DOI":"10.1016\/S0026-895X(24)23099-6"},{"key":"2026070808124296300_BEATO-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Beato\n              M\n            \n          , Herrlich P & Schutz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell83851\u2013857.","DOI":"10.1016\/0092-8674(95)90201-5"},{"key":"2026070808124296300_BENHAMOU-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Benhamou\n              B\n            \n          , Garcia T, Lerouge T, Vergezac A, Gofflo D, Bigogne C, Chambon P & Gronemeyer H 1992 A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science255206\u2013209.","DOI":"10.1126\/science.1372753"},{"key":"2026070808124296300_BLEDSOE-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Bledsoe\n              RK\n            \n          , Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM et al.2002 Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell11093\u2013105.","DOI":"10.1016\/S0092-8674(02)00817-6"},{"key":"2026070808124296300_BLEDSOE-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Bledsoe\n              RK\n            \n          , Madauss KP, Holt JA, Apolito CJ, Lambert MH, Pearce KH, Stanley TB, Stewart EL, Trump RP, Willson TM et al.2005 A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. Journal of Biological Chemistry28031283\u201331293.","DOI":"10.1074\/jbc.M504098200"},{"key":"2026070808124296300_BRZOZOWSKI-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Brzozowski\n              AM\n            \n          , Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA & Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature389753\u2013758.","DOI":"10.1038\/39645"},{"key":"2026070808124296300_CHEN-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Chen\n              S\n            \n          , Zhou D, Yang C & Sherman M 2001 Molecular basis for the constitutive activity of estrogen-related receptor alpha-1. Journal of Biological Chemistry27628465\u201328470.","DOI":"10.1074\/jbc.M102638200"},{"key":"2026070808124296300_DELYANI-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Delyani\n              JA\n            \n          , Rocha R, Cook CS, Tobert DS, Levin S, Roniker B, Workman DL, Sing YL & Whelihan B 2001 Eplerenone: a selective aldosterone receptor antagonist (SARA). Cardiovascular Drug Reviews19185\u2013200.","DOI":"10.1111\/j.1527-3466.2001.tb00064.x"},{"key":"2026070808124296300_FAGART-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Fagart\n              J\n            \n          , Huyet J, Pinon GM, Rochel M, Mayer C & Rafestin-Oblin ME 2005 Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nature Structural and Molecular Biology12554\u2013555.","DOI":"10.1038\/nsmb939"},{"key":"2026070808124296300_GAO-ETAL-1998","unstructured":"Gao\n              Y\n            \n          , Cheng L & Liu Y 1998 Failure of mifepristone induced interruption of pregnancy: point mutation at genetic codon 722 in human progesterone receptor gene. Zhonghua Fu Chan Ke Za Zhi33549\u2013552."},{"key":"2026070808124296300_GELLER-2001","doi-asserted-by":"crossref","unstructured":"Geller\n              DS\n            \n          \n          2001 A mineralocorticoid receptor mutation causing human hypertension. Current Opinion in Nephrology and Hypertension10661\u2013665.","DOI":"10.1097\/00041552-200109000-00018"},{"key":"2026070808124296300_GELLER-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Geller\n              DS\n            \n          , Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB & Lifton RP 2000 Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science289119\u2013123 (see comment).","DOI":"10.1126\/science.289.5476.119"},{"key":"2026070808124296300_KAUPPI-ETAL-2003","unstructured":"Kauppi\n              B\n            \n          , Jakob C, Farnegardh M, Yang J, Ahola H, Alarcon M, Calles K, Engstrom O, Harlan J, Muchmore S et al.2003 The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. Journal of Biological Chemistry27822748\u201322754."},{"key":"2026070808124296300_LI-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Li\n              Y\n            \n          , Suino K, Daugherty J & Xu HE 2005 Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Molecular Cell19367\u2013380.","DOI":"10.2210\/pdb2a3i\/pdb"},{"key":"2026070808124296300_LIM-TIO-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Lim-Tio\n              SS\n            \n          , Keightley MC, Fletcher TP & Fuller PJ 1996 The molecular basis of RU486 resistance in the Tammar wallaby, Macropus eugenii. Molecular and Cellular Endocrinology119169\u2013174.","DOI":"10.1016\/0303-7207(96)03807-5"},{"key":"2026070808124296300_MATIAS-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Matias\n              PM\n            \n          , Donner P, Coelho R, Thomaz M, Peixoto C, Macedo S, Otto N, Joschko S, Scholz P, Wegg A et al.2000 Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. Journal of Biological Chemistry27526164\u201326171.","DOI":"10.1074\/jbc.M004571200"},{"key":"2026070808124296300_NAWAZ-ETAL-1999","unstructured":"Nawaz\n              Z\n            \n          , Stancel GM & Hyder SM 1999 The pure antiestrogen ICI 182, 780 inhibits progestin-induced transcription. Cancer Research59372\u2013376."},{"key":"2026070808124296300_PINON-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Pinon\n              GM\n            \n          , Fagart J, Souque A, Auzou G, Vandewalle A & Rafestin-Oblin ME 2004 Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension. Molecular and Cellular Endocrinology217181\u2013188.","DOI":"10.1016\/j.mce.2003.10.053"},{"key":"2026070808124296300_RUPPRECHT-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Rupprecht\n              R\n            \n          , Reul JM, van Steensel B, Spengler D, Soder M, Berning B, Holsboer F & Damm K 1993 Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. European Journal of Pharmacology247145\u2013154.","DOI":"10.1016\/0922-4106(93)90072-H"},{"key":"2026070808124296300_SPITZ-AND-BARDIN-1993","unstructured":"Spitz\n              IM\n            \n           & Bardin CW 1993 Mifepristone (RU 486) \u2013 a modulator of progestin and glucocorticoid action. New England Journal of Medicine329404\u2013412."},{"key":"2026070808124296300_STIER-JR-2003","doi-asserted-by":"crossref","unstructured":"Stier\n              CT\n            \n           Jr 2003 Eplerenone: a selective aldosterone blocker. Cardiovascular Drug Reviews21169\u2013184.","DOI":"10.1111\/j.1527-3466.2003.tb00114.x"},{"key":"2026070808124296300_TEROUANNE-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Terouanne\n              B\n            \n          , Nirde P, Rabenoelina F, Bourguet W, Sultan C & Auzou G 2003 Mutation of the androgen receptor at amino acid 708 (Gly\u2013&gt;Ala) abolishes partial agonist activity of steroidal antiandrogens. Molecular Pharmacology63791\u2013798.","DOI":"10.1124\/mol.63.4.791"},{"key":"2026070808124296300_VEGETO-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Vegeto\n              E\n            \n          , Allan GF, Schrader WT, Tsai MJ, McDonnell DP & O\u2019Malley BW 1992 The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell69703\u2013713.","DOI":"10.1016\/0092-8674(92)90234-4"},{"key":"2026070808124296300_VICENT-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Vicent\n              GP\n            \n          , Monteserin MC, Veleiro AS, Burton G, Lantos CP & Galigniana MD 1997 21-Hydroxy-6,19-oxidoprogesterone: a novel synthetic steroid with specific antiglucocorticoid properties in the rat. Molecular Pharmacology52749\u2013753.","DOI":"10.1124\/mol.52.4.749"},{"key":"2026070808124296300_WARRIAR-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Warriar\n              N\n            \n          , Yu C & Govindan MV 1994 Hormone binding domain of human glucocorticoid receptor. Enhancement of transactivation function by substitution mutants M565R and A573Q. Journal of Biological Chemistry26929010\u201329015.","DOI":"10.1016\/S0021-9258(19)62006-5"},{"key":"2026070808124296300_WILLIAMS-AND-SIGLER-1998","unstructured":"Williams\n              SP\n            \n           & Sigler PB 1998 Atomic structure of progesterone complexed with its receptor. Nature393392\u2013396."},{"key":"2026070808124296300_ZHANG-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Zhang\n              J\n            \n          , Simisky J, Tsai FT & Geller DS 2005 A critical role of helix 3-helix 5 interaction in steroid hormone receptor function. PNAS1022707\u20132712.","DOI":"10.1073\/pnas.0409663102"},{"key":"2026070808124296300_ZILLICH-AND-CARTER-2002","doi-asserted-by":"crossref","unstructured":"Zillich\n              AJ\n            \n           & Carter BL 2002 Eplerenone \u2013 a novel selective aldosterone blocker. Annals of Pharmacotherapy361567\u20131576.","DOI":"10.1345\/1542-6270(2002)036<1567:EANSAB>2.0.CO;2"}],"container-title":["Journal of Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/jme\/article-pdf\/37\/1\/163\/64589\/0370163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/jme\/article-pdf\/37\/1\/163\/64589\/0370163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:12:48Z","timestamp":1783512768000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/jme\/article\/37\/1\/163\/11137\/Differential-interaction-of-RU486-with-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,8,1]]}},"URL":"https:\/\/doi.org\/10.1677\/jme.1.02089","relation":{},"ISSN":["1479-6813","0952-5041"],"issn-type":[{"value":"1479-6813","type":"electronic"},{"value":"0952-5041","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6,9]]}}}